Kevin Richard Haas
CIK: 0001843872
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Apr 10, 2026VCYT
VERACYTE, INC.
Award(A)Direct44.2K shares- - Mar 15, 2026MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct3.4K shares at avg. $4.66$16K - Mar 15, 2026MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct8.4K shares at avg. $4.66$39K - Mar 14, 2026MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct4.2K shares at avg. $4.66$19K - Mar 13, 2026MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct6.4K shares at avg. $4.66$30K - Feb 2, 2026MYGN
MYRIAD GENETICS INC
Award(A)Direct23.7K shares- - Mar 24, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct1.7K shares at avg. $9.98$17K - Mar 24, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct1.2K shares at avg. $9.98$12K - Mar 22, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct1.7K shares at avg. $10.01$17K - Mar 22, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct4.5K shares at avg. $10.01$45K - Mar 15, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct3.3K shares at avg. $10.07$34K - Mar 14, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct4.4K shares at avg. $10.07$44K - Mar 13, 2025MYGN
MYRIAD GENETICS INC
Award(A)Direct54.1K shares- - Feb 25, 2025MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct1K shares at avg. $11.74$12K - Feb 7, 2025MYGN
MYRIAD GENETICS INC
Award(A)Direct12.8K shares- - Oct 9, 2024MYGN
MYRIAD GENETICS INC
Tax Payment(F)Direct2.5K shares at avg. $24.37$61K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 10, 2026 | VCYT VERACYTE, INC. | Award(A) | 44,221 | - | $0 | Direct |
| Mar 15, 2026 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 3,355 | $4.66 | $15,634 | Direct |
| Mar 15, 2026 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 8,382 | $4.66 | $39,060 | Direct |
| Mar 14, 2026 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 4,161 | $4.66 | $19,390 | Direct |
| Mar 13, 2026 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 6,412 | $4.66 | $29,880 | Direct |
| Feb 2, 2026 | MYGN MYRIAD GENETICS INC | Award(A) | 23,697 | - | $0 | Direct |
| Mar 24, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 1,724 | $9.98 | $17,206 | Direct |
| Mar 24, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 1,177 | $9.98 | $11,746 | Direct |
| Mar 22, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 1,694 | $10.01 | $16,957 | Direct |
| Mar 22, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 4,493 | $10.01 | $44,975 | Direct |
| Mar 15, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 3,335 | $10.07 | $33,583 | Direct |
| Mar 14, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 4,390 | $10.07 | $44,207 | Direct |
| Mar 13, 2025 | MYGN MYRIAD GENETICS INC | Award(A) | 54,124 | - | - | Direct |
| Feb 25, 2025 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 1,016 | $11.74 | $11,928 | Direct |
| Feb 7, 2025 | MYGN MYRIAD GENETICS INC | Award(A) | 12,758 | - | - | Direct |
| Oct 9, 2024 | MYGN MYRIAD GENETICS INC | Tax Payment(F) | 2,515 | $24.37 | $61,291 | Direct |
1-16 of 16 transactions
About Haas Kevin Richard
Haas Kevin Richard (SEC CIK 0001843872) files insider reports with the SEC as Chief Dev and Tech Officer of VERACYTE, INC. (VCYT) and Chief Technology Officer of MYRIAD GENETICS INC (MYGN).
Signal8 holds 9 ownership filings by Haas Kevin Richard (1 Form 3, 8 Form 4), filed between Oct 10, 2024 and Apr 14, 2026. Those filings report 16 transactions, from Oct 9, 2024 to Apr 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Haas Kevin Richard's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Haas Kevin Richard
- Apr 10, 2026: Grant or award of VCYT shares (Form 4, code A).
- Mar 15, 2026: Tax withholdings of MYGN shares (2 lines, Form 4, code F).
- Mar 14, 2026: Tax withholding of MYGN shares (Form 4, code F).
- Mar 13, 2026: Tax withholding of MYGN shares (Form 4, code F).
- Feb 2, 2026: Grant or award of MYGN shares (Form 4, code A).
Other insiders filing for VERACYTE, INC. (VCYT)
- Wygant Jonathan, VP, Chief Accounting Officer
- Holstein Jens, Director
- EASTHAM KARIN, Director
- Bhanji Muna, Director
- Leite John, Global Chief Commercial Off
- Febbo Phillip G., Chief Scientific & Med Officer